Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma
Clinical trial NCT01740297 · COMPLETED
Trial details
- NCT number
- NCT01740297
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-07
- Primary completion
- 2016-08-23
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.